An innovative 'safety switch' for CAR T-cell therapy, designed at the Malaghan Institute and recently patented, has the potential to significantly enhance the safety and accessibility of this cutting-edge cancer immunotherapy and
https://twtr.to/AzmKY
https://ibit.ly/EhlUU
https://ibit.ly/RW8af
https://twtr.to/9cKW6
https://twtr.to/8WobA
https://twtr.to/S994S